CARDINAL COPD Clinical Research Study
HITS, IT HITS HARDER
That’s where you—and the CARDINAL study—come in. You may be eligible for a clinical research study looking into an investigational medicine to help reduce the effect the rhinovirus (common cold) has on people living with COPD.
CARDINAL=COPD And Rhinovirus-Decreasing INfection-related Acute Lower respiratory symptoms; COPD=chronic obstructive pulmonary disease; RSV=respiratory syncytial virus.
INTERESTED IN
PARTICIPATING?
Let’s
talk.
DO YOU QUALIFY?
- Age 45–85
- Diagnosed with COPD
- Experienced flare-ups or worsening breathing in the last year
WHAT CAN YOU EXPECT?
- Up to 7 study visits at a local research site
- Lab tests, health check-ups, and monitoring
- At-home nasal swabs for COVID/flu/RSV
- Daily at-home questionnaires on your phone or tablet
- The study medication (or placebo) provided at no cost
PATIENT COMPENSATION
Participants may receive payment for time and travel.
WHY ENROLL IN CARDINAL?
- Help advance COPD care
- Receive study-related treatment
- Be compensated for your participation
Please note: This study has been reviewed by an Institutional Review Board (IRB). The study medicine is investigational and has not been approved by the Food and Drug Administration (FDA).
